Patents by Inventor Angus John Morrison

Angus John Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino-heteroaryl derivatives as HCN blockers
    Patent number: 8952001
    Abstract: The invention relates to amino-heteroaryl derivatives having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of these derivatives for the treatment of pain, such as neuropathic pain or inflammatory pain.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: February 10, 2015
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Simon James Anthony Grove, Angus John Morrison, Craig Jamieson, Ronald Palin, John Kinnaird Ferguson Maclean
  • AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS
    Publication number: 20120264728
    Abstract: The invention relates to amino-heteroaryl derivatives having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of these derivatives for the treatment of pain, such as neuropathic pain or inflammatory pain.
    Type: Application
    Filed: December 20, 2010
    Publication date: October 18, 2012
    Inventors: Simon James Anthony Grove, Angus John Morrison, Craig Jamieson, Ronald Palin, John Kinnaird Ferguson Maclean
  • Compound and use thereof in the treatment of amyloidosis
    Patent number: 8236984
    Abstract: The present invention relates to compounds of formula (I) for stabilizing the tetrameric form of transthyretin, compounds for use in the treatment or prevention of amyloidosis, and agents and medicaments comprising such compounds. wherein X, Y, R1, R2, R3, R4, m, n, p, q, and the linker are as defined herein.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: August 7, 2012
    Assignee: Pentraxin Therapeutics Ltd.
    Inventors: Mark Brian Pepys, Steven Victor Ley, Angus John Morrison, Vittorio Bellotti, Simon Kolstoe, Martin Smith
  • COMPOUND AND USE THEREOF IN THE TREATMENT OF AMYLOIDOSIS
    Publication number: 20100249233
    Abstract: The present invention relates to compounds of formula (I) for stabilizing the tetrameric form of transthyretin, compounds for use in the treatment or prevention of amyloidosis, and agents and medicaments comprising such compounds. wherein X, Y, R1, R2, R3, R4, m, n, p, q, and the linker are as defined herein.
    Type: Application
    Filed: March 22, 2010
    Publication date: September 30, 2010
    Inventors: Mark Brian PEPYS, Steven Victor Ley, Angus John Morrison, Vittorio Bellotti, Stephen Wood, Simon Kolstoe, Martin Smith
  • Indole derivatives
    Patent number: 7763732
    Abstract: Disclosed herein are indole derivatives of the formula (I) wherein each of the substitutents is given the definition as set forth in the specification and claims. Also disclosed are pharmaceutical compositions containing the indole derivatives and use of the derivatives for the treatment of pain.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: July 27, 2010
    Assignee: N.V. Organon
    Inventors: Paul David Ratcliffe, Julia Adam-Worrall, Angus John Morrison, Stuart John Francis, Takao Kiyoi
  • (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
    Patent number: 7700634
    Abstract: Disclosed herein are indole derivatives of the formula (I) wherein each of the substitutents is given the definition as set forth in the specification and claims. Also disclosed are pharmaceutical compositions containing the indole derivatives and use of the derivatives for the treatment of pain.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: April 20, 2010
    Assignee: N.V. Organon
    Inventors: Julia Adam-Worrall, Angus John Morrison, Grant Wishart, Takao Kiyoi, Duncan Robert McArthur